Research Topics
| Richard G BoyesSummaryAffiliation: University College London Country: UK Publications
| Collaborators
|
Detail Information
Publications
Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integralRichard G Boyes
Dementia Research Centre, Institute of Neurology, Box 16, University College London, Queen Square, London WC1N 3BG, UK
Neuroimage 32:159-69. 2006..The results showed the Jacobian integration technique was significantly more accurate in calculating scaled atrophy (P < 0.001) and was able to distinguish between control and AD subjects more clearly (P < 0.01)...
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coilsRichard G Boyes
Dementia Research Centre, Institute of Neurology, Box 16, University College London, Queen Square, London, UK
Neuroimage 39:1752-62. 2008....
Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLDJosephine Barnes
Dementia Research Centre, University College London, Institute of Neurology, Queen Square, London, UK
Neurobiol Aging 28:20-8. 2007..Significantly better discrimination between AD and controls was obtained by hippocampal rather than cingulate rates. In conclusion, cingulate atrophy is as significant a feature of AD and FTLD as hippocampal atrophy...
Application of automated medial temporal lobe atrophy scale to Alzheimer diseaseBasil H Ridha
Dementia Research Centre, Institute of Neurology, University College London, WC1N 3BG, England
Arch Neurol 64:849-54. 2007..To compare an automated intensity-based measure of medial temporal atrophy in Alzheimer disease (AD) with existing volumetric and visually based methods...
Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progressionBasil H Ridha
Dementia Research Centre, Institute of Neurology, University College London, 8 11 Queen Square, London, WC1N 3BG, UK
J Neurol 255:567-74. 2008..Both cognitive tests and MRI-based measures have been suggested as outcomes in trials assessing disease-modifying therapies in Alzheimer's disease (AD)...
Differentiating AD from aging using semiautomated measurement of hippocampal atrophy ratesJosephine Barnes
Dementia Research Centre, Institute of Neurology, University College London, 8 11 Queen Square, WCIN 3BG, London, UK
Neuroimage 23:574-81. 2004..We conclude that HBSI-derived atrophy rates reduce operator time and error, and are at least as effective as the manual equivalent as a diagnostic marker and are a potential marker of progression in longitudinal studies and trials...
Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associationsMatthew C Evans
Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK
Eur Radiol 20:674-82. 2010..To assess the relationship between MRI-derived changes in whole-brain and ventricular volume with change in cognitive scores in Alzheimer's disease (AD), mild cognitive impairment (MCI) and control subjects...
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometryXue Hua
Laboratory of Neuro Imaging, Department of Neurology, UCLA School of Medicine, Neuroscience Research Building 225E, Los Angeles, CA 90095 1769, USA
Neuroimage 41:19-34. 2008..In the future, TBM may help to (1) identify factors that resist or accelerate the disease process, and (2) measure disease burden in treatment trials...
